Table 1

 Demographics, clinical settings, culture sites, and type of organism

Patient NoAge (years)SexGlaucoma diagnosisMitomycin C useImplant locationType of patch graftInterval (days*)Duration (days†)Presenting visual acuityTube erosionCulture siteOrganism(s)
AC, anterior chamber; CF, counting fingers; F, female; HM, hand movements; LP, light perception; IT, inferotemporal; M, male; NR, not recorded since patient was sedated; SN, superonasal; ST, superotemporal; VIT, vitreous.
*Interval between AGVI surgery and endophthalmitis diagnosis; †duration of symptom before diagnosis of endophthalmitis.
10.8FCongenital glaucomaYesITSclera637NRNoAC, VITHaemophilus influenzae, Streptococcus pneumoniae
21FCongenital glaucomaYesSTPericardium305NRYesAC, VIT Streptococcus pneumoniae
31FCongenital glaucomaYesITDura1042NRYesVITNo growth
42MCongenital glaucomaYesSTDura2705LPNoVIT Streptococcus pneumoniae
56FSecondary glaucomaYesSTDura2102CFYesAC, VIT Haemophilus influenzae
643MSecondary glaucomaYesSTSclera1804CFYesAC, VITNo growth
760FSecondary glaucomaYesSNSclera3001HMYesVIT Streptococcus agalactiae
878MSecondary glaucomaNoSTDura3062CFNoVIT Streptococcus mitis
963MPrimary glaucomaNoSTDura3305Poor LPYesVIT Pseudomonas aeruginosa